Clinical Trial Update: Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update indicates daily adaptive radiation therapy using an individualized approach for prostate cancer is currently in the recruiting phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Prostate Cancer | NA | Status: RECRUITING